Pregabalin in the treatment of neuropathic tremor following a motor axonal form of Guillain-Barré syndrome

Movement Disorders

Volumn 25, Issue 4, 2010, Pages 517-519

  Coltamai, Lionel ^a   Magezi, David A ^a   Croquelois, Alexandre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PREGABALIN; PRIMIDONE; PROPRANOLOL DERIVATIVE;

ADULT; CAMPYLOBACTER JEJUNI; CASE REPORT; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; DRUG DOSE INCREASE; ELECTROMYOGRAPHY; ESSENTIAL TREMOR; GUILLAIN BARRE SYNDROME; HUMAN; LETTER; MALE; MONOTHERAPY; NEUROPATHIC TREMOR; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PARESIS; PRIORITY JOURNAL; QUADRIPLEGIA; SEROLOGY; TREMOR;

ADULT; ANTICONVULSANTS; AXONS; GAMMA-AMINOBUTYRIC ACID; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MOTOR NEURONS; PERIPHERAL NERVES; REST; SEVERITY OF ILLNESS INDEX; TREMOR;

EID: 77949533330     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22961     Document Type: Letter

References (7)

1. Zesiewicz TA, Ward CL, Hauser RA, et al. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord 2007;22:1660-1663.
2. Deuschl G, Raethjen J, Lindemann MS, et al. The pathophysiology of tremor. Muscle Nerve 2001;24:716-735.
3. Alonso-Navarro H, Fernádez-Diaz A, Martín-Prieto M, et al. Tremor associated with chronic inflammatory demyelinating peripheral neuropathy: treatment with pregabalin. Clin Neuropharmacol 2008;31:241-244.
4. Deuschl G, Bergman H. Pathophysiology of nonparkinsonian tremor. Mov Disord 2002;17:S41-S48.
5. Fahn S, Tolosa E, Concepcion M. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders, 2nd ed. Baltimore: William and Wilkins; 1993. p 271-280.
6. Bain PG, Britton TC, Jenkins IH, et al. Tremor associated with benign IgM paraproteinaemic neuropathy. Brain 1996;119:789-799.
7. A receptor α1 subunit knockout mice. J Clin Invest 2005;115:774-779.